AARD vs AAPL · $284.4M cap vs P/E 39, rev $416.16B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
AARD currently screens at market cap $284.4M. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the AARD and AAPL stock pages for the full models.
Not investment advice.